A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis
- PMID: 21827658
- PMCID: PMC3169460
- DOI: 10.1186/1477-7827-9-113
A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis
Abstract
Background: Endometriosis is associated with chronic subclinical inflammation. C-reactive protein (CRP), a marker of inflammation, could serve as a biomarker of endometriosis. We tested the hypothesis that a high sensitivity CRP assay (hsCRP) is more accurate than a classical CRP assay in the detection of subclinical inflammation in plasma of women with endometriosis.
Methods: CRP levels were measured by hsCRP and classical CRP assays in plasma of 204 women with endometriosis and 91 women without endometriosis. Both assays were compared with respect to their value for the diagnosis of endometriosis.
Results: The number of plasma samples with detectable CRP was significantly higher (100%) using the hsCRP assay when compared to the classical CRP assay (42.7%) (p < 0.0001). Significantly increased CRP plasma levels were found in women with endometriosis when compared with controls when the hsCRP assay was used in samples obtained during the luteal phase (p = 0.008). The highest discriminative ability for the diagnosis of endometriosis was also obtained using the hsCRP assay during the luteal phase, especially for moderate -severe endometriosis. At a cut-off level of hsCRP > 0.71 mg/L, moderate-severe stages were diagnosed with 80.7% sensitivity and 63.9% specificity during the luteal phase. Using a similar cut-off value for CRP analyzed by the classical method, moderate-severe endometriosis was diagnosed with lower sensitivity (67.7%, p = 0.06) and comparable specificity (63.9%).
Conclusions: The hsCRP assay was superior to the classical CRP assay for the detection of low CRP levels and for revealing subclinical inflammation in plasma of women with endometriosis.
Figures

Similar articles
-
Evaluation of high-sensitivity C-reactive protein in comparison with C-reactive protein as biochemical serum markers in women with endometriosis.Fertil Steril. 2010 May 1;93(7):2125-9. doi: 10.1016/j.fertnstert.2009.01.072. Epub 2009 Feb 15. Fertil Steril. 2010. PMID: 19232412 Clinical Trial.
-
Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers.Hum Reprod. 2010 Mar;25(3):654-64. doi: 10.1093/humrep/dep425. Epub 2009 Dec 9. Hum Reprod. 2010. PMID: 20007161
-
Measurement of hs-CRP is irrelevant to diagnose and stage endometriosis: prospective study of 834 patients.Am J Obstet Gynecol. 2014 Jun;210(6):533.e1-533.e10. doi: 10.1016/j.ajog.2014.01.022. Epub 2014 Jan 17. Am J Obstet Gynecol. 2014. PMID: 24440563
-
Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker.Am J Clin Pathol. 2001 Dec;116 Suppl:S108-15. doi: 10.1309/J63V-5LTH-WYFC-VDR5. Am J Clin Pathol. 2001. PMID: 11993695 Review.
-
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus.Diabetes Technol Ther. 2006 Feb;8(1):28-36. doi: 10.1089/dia.2006.8.28. Diabetes Technol Ther. 2006. PMID: 16472048 Review.
Cited by
-
Prognostic Value of High-Sensitivity C-Reactive Protein in In-Stent Restenosis: A Meta-Analysis of Clinical Trials.J Cardiovasc Dev Dis. 2022 Aug 4;9(8):247. doi: 10.3390/jcdd9080247. J Cardiovasc Dev Dis. 2022. PMID: 36005411 Free PMC article. Review.
-
Analysis of Changes in Serum Levels and Gene Expression Profiles of Novel Adipocytokines (Omentin, Vaspin, Irisin and Visfatin) and Their Correlation with Serum C-reactive Protein Levels in Women Diagnosed with Endometriosis.Turk J Pharm Sci. 2022 Feb 28;19(1):48-53. doi: 10.4274/tjps.galenos.2021.52284. Turk J Pharm Sci. 2022. PMID: 35227049 Free PMC article.
-
Iron status in women with infertility and controls: a case-control study.Front Endocrinol (Lausanne). 2023 Jun 8;14:1173100. doi: 10.3389/fendo.2023.1173100. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37361544 Free PMC article.
-
Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis.Int J Mol Sci. 2021 Feb 25;22(5):2295. doi: 10.3390/ijms22052295. Int J Mol Sci. 2021. PMID: 33669013 Free PMC article.
-
Update on Biomarkers for the Detection of Endometriosis.Biomed Res Int. 2015;2015:130854. doi: 10.1155/2015/130854. Epub 2015 Jul 9. Biomed Res Int. 2015. PMID: 26240814 Free PMC article. Review.
References
-
- Mihalyi A, Kyama CM, Simsa P, Debrock S, Mwenda JM, D'Hooghe TM. Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies. Therapy. 2005;2:623–639. doi: 10.2217/14750708.2.4.623. - DOI
-
- D'Hooghe TM, Debrock S, Hill JA, Meuleman C. Endometriosis and subfertility: Is the relationship resolved? Semin Reprod Med. 2003;21:243–254. - PubMed
-
- Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Dionyssopoulou E, Athanassakis I, Vassiliadis S. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol. 2003;3:81–89. doi: 10.1016/S1567-5769(02)00216-3. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous